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Abstract 
The structural properties of three immunoglobulins light chains: K SCI, responsible for light chain deposition disease (Bellotti, V., 
Stoppini, M., Merlini, G., Zapponi, M.C., Meloni, M.L., Banff, G. and Ferri, G. (1991) Biochim. Biophys. Acta 1097, 177-182), k INC 
responsible for light chain amyloidosis (Ferri, G., Stoppini, M., Iadarola, P., Bellotti, V. and Merlini, G. (1989) Biochim. Biophys. Acta 
995, 103-108) and the non-pathogenic K MOS were analyzed by fluorescence spectroscopy and circular dichroism. 
Comparative evaluation of the data shows that SCI and MOS have similar stability under different conditions, while the amyloid k 
INC behaves as a very unstable protein. 
As calculated from the GdnHC1 curves, the midpoint of unfolding transition was 1.35 M for SCI, 1.20 M for MOS and 0.1 M for INC. 
Analysis of CD spectra evidences that the three proteins conserve their conformation i the range of pH 4-8. Change in temperature at 
pH 4.0 produces the premature transition of INC (T m 40°C) with respect o SCI and MOS (T m 50°C). At this pH both the pathological 
SCI and INC light chains aggregate ata temperature of 20°C lower than the normal counterpart. The specific kidney deposition of K SCI 
has been evidenced after injection of the 1251 labelled light chain into mice. No deposition was detectable in the case of INC and MOS. 
Keywords: Light chain; Light chain deposition disease; Amyloidosis; Unfolding 
I. Introduction 
Tissue deposition of immunoglobulin monoclonal light 
chain is characteristic of two distinct clinical entities: light 
chain (AL) amyloidosis and light chain deposition disease 
(LCDD). In the former disease the pathological light chain 
creates a typical fibrillar and Congo red birefringent aggre- 
gate in target issues; in the latter the protein is localized in 
the basement membrane, without the fibrillar pattern [1]. 
The primary structure of pathogenic light chains has been 
Abbreviations: LCDD, light chain deposition disease; GdnHCI, guani- 
dine hydrochloride; pl, isoelectric point; PMSF, phenyl methyl sul- 
fonylfluoride; PAS, periodic acid Schiff's reagent; DTT, dithiothreitol; 
CD, circular dichroism; T m, midpoint of temperature unfolding transition; 
C m, midpoint of GdnHCI unfolding transition; ECL, enhanced chemilu- 
minescence 
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extensively investigated in order to understand the molecu- 
lar basis of this disease, and the aminoacid sequence of 
more than 60 amyloidogenic light chains has been reported 
so far. In contrast, only 4 light chains associated with 
LCDD have been completely sequenced [2-5]. 
The search for common structural functional character- 
istics of amyloidogenic light chains over the last few years 
has been unsatisfactory due to the extreme variability of 
the VL domain, although recurrent amino acid replace- 
ments have been identified in certain positions [6]. It has 
been reported that some of these mutations introduced into 
synthetic DNA encoding the VL domain of the non patho- 
logical REI light chain reduce protein stability and facili- 
tate aggregation i to amyloid-like fibrils [7]. Reduced sta- 
bility seems to be a property not only of these mutants, but 
also of amyloidogenic transthyretin [8] and cystatin C [9]. 
The paucity of structural data regarding the immuno- 
globulins responsible for LCDD has not permitted the 
identification of putative pathogenic mutations and the 
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thermodynamic properties of these light chains are at the 
present unknown. 
In this paper we present a comparative study on thermo- 
dynamic haracterization a d tissue distribution pattern in 
an in vivo model of a complete light chain (K SCI) 
associated with LCDD and of an amyloidogenic light 
chain (K INC), whose amino acid sequence were previ- 
ously reported [2,10]. By way of comparison, we also 
studied the properties of a K light chain clinically consid- 
ered non pathological. 
2. Materials and methods 
2.1. Materials 
Two immunoglobulin light chains responsible for LCDD 
(kSCI) [2] and AL amyloidosis (K INC) [10] were purified 
from the urine of two patients submitted to periodical 
clinical check-ups. Diagnosis of the associated isease 
suggested by clinical presentation, was confirmed by spe- 
cific tissue biopsy staining. The light chains K MOS and A 
GAR were referred as non pathological; neither the former, 
excreted at the level of 5 g/day, nor the latter excreted at 
the level of 17 g/day caused any syndrome associated 
with tissue deposition in three years of follow-up. 
The following materials were obtained from commer- 
cial sources given in parentheses: reagents and protein 
standards for isoelectrophocusing and PAGE electrophore- 
sis (Bio Rad Richmond, CA, USA); Superose G12 column, 
Sephadex G25 (Pharmacia, Uppsala, Sweden); ECL, 
Na125I, Nal31I (Amersham, Buckinghamshire, UK); Immo- 
bilon, acrodisc filters (Millipore, Bedford, MA, USA). 
Reagents used for automated sequence analysis were sup- 
plied by Hewlett-Packard (Palo Alto, CA, USA). All the 
other reagents were from Sigma (St. Louis, MO, USA). 
2.2. Methods 
2.2.1. Protein purification and structural analysis 
Protein purification was conduced as previously re- 
ported by a combination of ammonium sulfate precipita- 
tion, ion exchange chromatography and gel filtration [2]. 
Size exclusion chromatography was performed at room 
temperature in a Superose G12 column using an FPLC 
apparatus; the column was equilibrated in 20 mM Tris-HC1, 
0.15 M NaCI, pH 7.4. 
SDS-PAGE in reducing and non-reducing conditions 
was carded out according to Laemmli [11] and stained 
with Coomassie blue and PAS. 
Immunoblotting and isoelectrophocusing i  6 M urea 
were performed as previously described [12]. Standard 
proteins were used as pl  markers. 
The protein concentration was determined by amino 
acid analysis or spectrophotometrically t 280 nm with 
A l%/1  cm = 13.0. 
Amino acid analysis was performed on a Kontron Chro- 
makon 500 automated analyzer according to Moore [13]. 
The N-terminal sequence of K MOS was determined by 
adsorptive biphasic column technology using an 
HPG1000A protein sequenator (Hewlett-Packard, Palo 
Alto, CA) with the routine 3.0 chemistry method and 
PTH 4M HPLC method. 
2.2.2. Fluorescence measurements 
Fluorescence spectra in the range 300-450 nm were 
measured with a Perkin Elmer LS50 spectrofluorimeter at 
20°C on protein samples, 0.44/zM in 20 mM K phosphate 
buffer, pH 7.4. Thermodynamic stability of the light chains 
was determined by monitoring the dependence of intrinsic 
tryptophan fluorescence on GdnHCI concentration. The 
protein in the same solution was excited at 295 nm and 
emission was monitored at 345 nm [14]. The transition 
curves were analyzed as suggested by Finn et al. [15]. 
2.2.3. Circular dichroism 
CD measurements were performed with a Jasco 710 
spectropolarimeter equipped with a thermostated cell holder 
and a temperature controlled system. Temperature was 
monitored using a Microtherm 1006 thermometer and a 
S /N  117C temperature probe just outside the sample cell. 
Measurements were performed in cells with 0.1 cm and 1 
cm path lengths in the far (190-250 nm) and in the near 
UV (250-310 nm), respectively. 
Protein was dissolved in 20 mM K phosphate buffer at 
different pH and at a concentration of 2.2 /~M (far UV) 
and 8.8 /xM (near UV). The elipticity was recorded every 
1 s with a response time of 1 s and a band width of 2 nm. 
Elipticities in deg cm 2 dmol-1 were expressed as [0]. 
Thermal denaturation i the far UV region was monitored 
by calculating [ 0 ]220 + [0 ]200 and in the near UV region 
by measuring changes of [ 0 ] at 280 nm. Elipticity readings 
were normalized to fraction unfolded (Fu) using the equa- 
tion 
Fu = [0]  - [0 ] , / [0 ]u  - [0]N 
where [0] U and [ 0] N represent respectively the elipticity 
values for the fully unfolded and fully folded state at each 
temperature. 
2.2.4. Light scattering 
Light scattering measurements were performed in a 
Perkin Elmer LS50 spectrofluorimeter equipped with a 
thermostated cell holder and a temperature controlled sys- 
tem. The aggregation was monitored in a temperature 
gradient. Samples were excited at 510 nm and the scattered 
light was detected at 90 ° to the incident beam; the spectral 
band was 2.5 nm. Protein concentration was 13.2 /xM in 
20 mM K phosphate buffer, pH 4.0. Signals were corrected 
for the blank value. 
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Fig. 1. Size exclusion chromatography of the light chains. Protein samples were subjected tosize exclusion FPLC on a Superose GI2 column. Elution was 
performed at room temperature, at a flow rate of 0.3 ml/min using 20 mM Tris-HC1, 0.15 M NaCI buffer, pH 7.4, as eluent. Inset: Molecular mass 
determination. Standard samples: 1 = bovine serum albumin (66 kDa), 2 = A1 protein (34 kDa), 3 = fl-2-microglobulin (11.7 kDa), 4 = insulin (5.7 kDa) 
5 = riboflavin (376 Da). 
2.2.5. Fibrillogenesis and electron microscopy 
Fibrillogenesis n vitro was carried out by submitting 
the insoluble precipitates of the light chains to pepsin 
digestion as suggested by Linke et al. [16]. Protein aggre- 
gate was directly visualized by electron microscopy on 
grids covered with a carbon-stabilized Formvar film after 
negative staining with 2% sodium phosphotungstate in 
water. 
2.2.6. Quantitation of light chains deposition 
Light chain deposition in mouse organs was evaluated 
following the method of Wilson and Dixon [17] with 
minor modifications. 2 mg of K and 2 mg of AGAR light 
chain were labeled with ]251 and 1311, respectively, using 
the chloramine-T method, and the free iodine was cleared 
by gel filtration on Sephadex G25. Free iodine was no 
more than 10% in the labelled protein preparation. 0.5 ml 
of a solution containing 0.5 mg of 125I-K light chain and 
0.6 mg of 131I-h light chain in phosphate buffered saline 
(PBS), was injected via the tail vein in male BALB/c  
mice. After 1 h the mice were killed by exsanguination. 
Heparinized blood was collected, kidney, liver and spleen 
samples were weighted, diced and homogenized in a chilled 
Polytron homogenizer. The excess of radioactivity was 
eliminated by washing the precipitate with PBS. Radioac- 
tivity was determined in a gamma scintillation counter and 
the specific organ uptake of the radiolabelled probes was 
calculated by using the standard formula: 
organl25I - organ 131I × blood125I 
specific organ1251 = blood 1311 
2.2.7. Electrophoretic analysis of light chains extracted 
from the mouse kidney 
In a separate xperiment, 3 mice were injected with 0.5 
ml of a solution of K SCI, n INC and K MOS (1 mg/ml  
Table 1 
N-terminal sequence of ~¢ MOS 
1 D I Q M T Q S P S T 
20 I I T C R A S Q D I 
39 K P G K A P E V L I 
58 V P 
L S A S V G D R V 
S S R L A W F Q Q 
Y D A S I L Q S G 
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Fig. 2. Fluorescence mission spectra of the light chains. The spectra 
were recorded from 300 to 450 nm in 20 mM K phosphate buffer, pH 7.4 
using a 0.44/zM protein concentration. Excitation was set at 295 nm. The 
spectra shown were obtained after correcting for the buffer spectrum. 
I=K MOS;2=K SC I ;3=r  INC. 
in PBS). After 1 h, kidneys were removed, diced, homoge- 
nized in PBS containing 15 mM PMSF, centrifuged at 
10,000 rpm for 30 minutes at 4°C and reextracted 7 times 
until the A280 of the supernatant was < 0.10. The resultant 
pellet was homogenized in 1 ml of Laemmli sample buffer 
(40 mM Tris-HC1, 10 mM EDTA and 1% SDS, pH 8.0), 
boiled for 3 minutes and 10 /zl of this solution were 
analyzed by SDS-PAGE electrophoresis according to 
Laemmli [11] using an acrylamide gradient 5-15%. The 
gel was blotted on immobilon membrane and immuno- 
stained with and-r antibodies as previously described [12] 
using the ECL system according to the manufacturer's 
suggestions. 
3. Results 
3.1. Protein structure studies 
The light chains used in the present study (MOS, SCI, 
INC) were obtained from human urine. Gel filtration anal- 
ysis (Fig. 1) demonstrated that all the samples were dimers, 
free of high molecular weight contaminants accounting for 
light chain aggregates [18], as well as of light chain 
fragments frequently present in amyloidogenic Bence Jones 
proteins [15]. From the known primary structure, it appears 
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Fig. 3. Unfolding transition of the light chains induced by GdnHCI. 
Samples (0.44/xM in 10 mM K phosphate buffer and GdnHCI from 0 to 
4 M, pH 7.4) were equilibrated at 20°C for 4 h before fluorescence was 
monitored. Excitation was set at 295 nm, emission at 345 rim. Data were 
the mean of three independent measurements and were converted to Fapp 
[15]. 
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Fig. 4. Unfolding transition of the light chains induced by temperature. 
CD spectra were recorded at the indicated temperature in 20 mM K 
phosphate buffer, pH 4.0. Protein concentration was 2.2 /zM in the far 
UV; 8.8 /zM in the near UV. Unfolded fraction was calculated from the 
contribution of the ellipticity at 220 and 200 nm (A) and from the 
ellipticity at 280 nm (B). Fraction unfolded I = ellipticity at 70°C; 
0 = ellipticity in the range 4-20°C. Data are the mean of three indepen- 
dent measurements. 
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Fig. 5. Aggregation of the light chains induced by temperature. Light 
scattering was monitored at the indicated temperature in 20 mM K 
phosphate buffer, pH 4.0. Samples (13.2 /~M) were excited at 510 nm 
and scattered light was detected at 90 ° to the incident beam. 
that the amyloidogenic INC [10] is a K II light chain 
constituted by 219 residues, and that K SCI, associated 
with LCDD, is a 214-residue K IIIa light chain [2]. 
Characterization of the non-pathogenic light chain MOS, 
accomplished by amino acid composition, molecular weight 
determination and N terminal sequence analysis (Table 1), 
indicates that this protein is also a complete K I light 
chain. PAS stain of the three proteins, after PAGE elec- 
trophoresis, was negative thus excluding the presence of 
linked carbohydrates. 
The isoelectrofocusing analysis gave the following val- 
ues for the pl  of the proteins: 6.4 (K MOS); 6.9 (K SCI); 
4.4 (K INC). Fluorescence analysis shows that the proteins 
have similar spectra, with a maximum centered between 
340 and 350 nm (K MOS = 344 nm, K INC = 347 nm, K 
SCI = 342 nm); however, the fluorescence intensity of K 
INC in its native conformation is approximately double 
than that of SCI and MOS (Fig. 2), even though the Trp 
content is the same in these proteins. 
In order to analyze the folding stability we character- 
ized the response of the three light chains to GdnHC1 by 
monitoring the unfolding-dependent increase in Trp fluo- 
rescence. Fig. 3 shows that K SCI and K MOS present 
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after reduction with 1 mM DTT. 
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very similar characteristics; their transition curves are sig- 
moidal and do not indicate a stable unfolding intermediate, 
suggesting that the proteins achieve the unfolded state 
through a single phase transition [19]. The calculated Cm 
was 1.35 M for K SCI, 1.20 M for K MOS. The AG~ 2°, 
calculated as suggested by Pace et al. [19], was 5.6 
kcal/mol for K SCI and 5 kcal/mol for K MOS. 
In contrast, the amyloidogenic light chain INC appears 
to be an extremely unstable protein. Its unfolding midpoint 
is 0.1 M and the AG~ 2° was not calculated because an 
incomplete denaturation curve was obtained. 
The effect of pH on the secondary structure of the three 
light chains was studied by measuring CD spectra in the 
far UV region, and the results were in good agreement 
with those obtained by Azuma et al. with K and A Bence 
Jones proteins [20]. The /3 sheet secondary structure is 
conserved in the three light chains in the range of pH 4-8, 
while a partially unfolded state is present at pH 3.0. At pH 
2.0 the three immunoglobulins assume a random coil 
structure (data not shown). 
The effect of the temperature atpH 4.0 was monitored 
in the near and far UV regions by raising the temperature 
from 20 to 70°C. The results illustrated in Fig. 4 show that 
in the far and in the near UV region the transition midpoint 
(Tm,) is 50°C for MOS and SCI and 40°C for INC. No 
aggregation can be observed, even in conditions of com- 
plete denaturation, at a protein concentration lower than 
13.2 /zM. Fig. 5 shows that at this concentration and pH 
4.0, the aggregation of SCI and INC starts at very similar 
temperature (52°C and 50°C respectively), whereas ahigher 
temperature is required for MOS (70°C). No fibrillar ultra- 
structure is visible by electron microscopy analysis of the 
insoluble precipitate. A small amount of fibrils were de- 
tected only in the case of K INC after submitting its 
precipitate to pepsin digestion according to Linke et al. 
[16]. 
3.2. Tissue distribution o f  light chains in mice 
The specific binding of K SCI to mouse tissues is 
shown in Fig. 6. In all the treated animals, one hour after 
the intravenous injection of the labelled light chain, a 
significant amount of K SCI is accumulated in the kidney, 
liver and spleen. The amount of protein in the kidney is 3 
to 5 times higher than in the other two tissues. 
Tissues were blindly analyzed by direct immunofluo- 
rescence with anti-K and anti-A light chains, which demon- 
strated faint K chain deposition within the glomerulus and 
along the tubular and vascular basement membranes. Light 
microscopy findings were negative. No tissue deposition 
can be evidenced after injection of K MOS, K INC and A 
GAR. 
In separate xperiments, the light chains SCI, INC and 
MOS were injected in mice and the material extracted 
from the kidneys was submitted to electrophoretic analysis. 
As shown in the insert of Fig. 6, after injection of K SCI, a 
substantial amount of K light chain is evidenced in the 
kidney extract. The data also indicate that the injected K 
SCI is not significatively modified during kidney accumu- 
lation: it behaves as a dimer in non reducing conditions 
(lane b) and as a monomer after the addition of 1 mM 
DTT (lane e). Aspecific high molecular weight bands are 
also present in the control (see lane b and c). The material 
extracted from mice injected with light chain INC and 
MOS (data not shown) did not show any positive stain. 
4. Discussion 
The data obtained with our in vivo model evidence that 
the light chain SCI, responsible for LCDD, in its mature 
and dimeric form is deposited in kidney, liver and spleen. 
The kidney is more effective than the other tissues in 
retaining the radiolabelled protein. Moreover enal deposi- 
tion of K SCI appears to be a specific process: infact the 
control K and A light chains as well as the amyloidogenic 
K INC are not retained even in this organ which is known 
to be the major metabolic site of these proteins [21]. Renal 
uptake of pathological light chains has also been observed 
by Solomon et al. [22] and Khamlichi et al. [23] using a 
different experimental protocol. Our data, in addition, point 
out the rapid accumulation of K SCI in the kidney. As 
judged by the electrophoretic analysis, this process occurs 
without substantially remodelling of the protein structure. 
The absence of a lag phase in the kidney deposition of the 
LCDD associated protein might exclude a nucleation step 
which, on the contrary, seems to be necessary in amyloid 
formation [6]. 
Both the different deposition behaviour and the ultra- 
structural organization of the insoluble deposit focus atten- 
tion on distinctive structural properties of the light chain 
responsible for the two diseases. Significant differences are 
evidenced in the present study by comparing some molecu- 
lar properties of the light chains associated with AL amy- 
loidosis and LCDD, with those of a non pathological 
counterpart. 
The folding stability of K SCI is similar to that of the 
non pathological K MOS: C m values of 1.35 and 1.20 M 
were obtained for the former and the latter respectively by 
monitoring the unfolding dependent increase of fluores- 
cence as a function of denaturant concentration. These 
values agree with those previously reported by Rowe and 
Tanford [24] and Tsunenaga et al. [14] for non pathological 
light chains; both are slightly lower than that found for the 
recombinant VL domain of Rei light chain [7]. Similar 
stability is also evidenced by analysing the CD spectra of 
the proteins under different pH and temperature conditions. 
Both the proteins how considerable stability in the far UV 
range above pH 4.0. The effect of the temperature at this 
pH is identical: the two proteins go through a transition of 
the secondary and tertiary structure above 40°C. In con- 
trast, as previously suggested on the basis of its primary 
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structure [10], K INC is a very unstable protein; the C m 
(0.1 M) is lower even with respect o that of the amyloido- 
genic point mutant R 61 of REI VL domain [7] in which 
the charged residue, as in INC [10], is replaced by an 
uncharged one. This behaviour and the high intrinsic fluo- 
rescence in non-denaturing condition suggest hat Trp 95 is 
not completely quenched by the Cys 23-Cys 88 disulfide 
bridge [7], probably because a partially unfolded state is 
already present in the native protein. In accordance with 
the fluorescence data, the thermal denaturation of K INC 
occurs about 10°C below with respect o the MOS counter- 
part. Thus amino acid replacements and folding instability 
appear to be related to the amyloid trait not only in 
transthyretin and cystatin mutants but also in a naturally 
occurring amyloid light chains. These data support the 
hypothesis that destabilizing amino acid replacements can 
induce a partially folded state prone to protein aggregation 
and fibril formation [7]. 
Although different in folding stability, the LCDD asso- 
ciated SCI and the amyloid INC share the property to self 
aggregate in vitro at 50°C under acidic conditions (pH 
4.0). From the isoelectric point of the proteins it may be 
expected that the charge modification, induced by pH, may 
more affect INC than SCI self aggregation, since at this 
pH, the former may have a net charge near zero, the latter 
should be dissociated at a similar extent as the control. The 
review of the available primary structures of light chains 
responsible for LCDD has stand out the presence of un- 
usual hydrophobic residues in positions generally occupied 
by hydrophilic or neutral amino acids [25]. This character- 
istic is shared by K SCI which presents Ile in position 53 
and 77 respectively occupied by Asn and Ser in REI light 
chain and generally by polar residues in K and A light 
chains. This suggests that the presence of such a bulky 
apolar side chains that, according to the X ray structure of 
K REI [26], are both located in regions exposed to the 
solvent, may prime the aggregation of the unfolded protein 
through intermolecular hydrophobic interactions. 
In conclusion, the rapid and specific tissue accumula- 
tion and the tendency to in vitro aggregation of the protein 
in its unfolded state, support he hypothesis that deposition 
of the LCDD associated K SCI may occur in vivo through 
a two step process. At the beginning the monoclonal light 
chain binds a still unknown component of the basement 
membrane, accumulates and reach a high concentration i
the kidney; later on, protein aging and local conditions 
could cause unfolding and self aggregation that enhance 
the deposition of insoluble light chain precipitate. 
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